These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24383847)

  • 1. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
    Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
    Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
    Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
    Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased adhesive properties of eosinophils in sickle cell disease.
    Canalli AA; Conran N; Fattori A; Saad ST; Costa FF
    Exp Hematol; 2004 Aug; 32(8):728-34. PubMed ID: 15308324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
    Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
    Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
    Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
    Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
    Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
    J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.
    Assis A; Conran N; Canalli AA; Lorand-Metze I; Saad ST; Costa FF
    Acta Haematol; 2005; 113(2):130-6. PubMed ID: 15802892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide.
    Lintomen L; Franchi G; Nowill A; Condino-Neto A; de Nucci G; Zanesco A; Antunes E
    BMC Pulm Med; 2008 Aug; 8():13. PubMed ID: 18700028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
    El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior exposure of endothelial cells to hydroxycarbamide alters the flow dynamics and adhesion of sickle red blood cells.
    Verger E; Schoëvaërt D; Carrivain P; Victor JM; Lapouméroulie C; Elion J
    Clin Hemorheol Microcirc; 2014; 57(1):9-22. PubMed ID: 24002118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
    Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
    Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.
    Styles LA; Lubin B; Vichinsky E; Lawrence S; Hua M; Test S; Kuypers F
    Blood; 1997 Apr; 89(7):2554-9. PubMed ID: 9116302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation.
    Chaar V; Laurance S; Lapoumeroulie C; Cochet S; De Grandis M; Colin Y; Elion J; Le Van Kim C; El Nemer W
    J Biol Chem; 2014 Apr; 289(16):11512-11521. PubMed ID: 24616094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease.
    Laurance S; Pellay FX; Dossou-Yovo OP; Verger E; Krishnamoorthy R; Lapoumeroulie C; Benecke A; Elion J
    Pharmacogenet Genomics; 2010 Apr; 20(4):257-68. PubMed ID: 20216336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
    Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
    J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Ribeiro PR; Teixeira RDS; Souza AR; Pereira TCS; Boffo EF; Carosio MGA; Ferreira AG; Oliveira RV; Rodrigues LEA; Silva JJ; de Souza AJ; Ladeia AMT
    Br J Haematol; 2021 Mar; 192(5):922-931. PubMed ID: 33476407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
    Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
    Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.
    Silva DG; Belini Junior E; Torres Lde S; Ricci Júnior O; Lobo Cde C; Bonini-Domingos CR; de Almeida EA
    Blood Cells Mol Dis; 2011 Jun; 47(1):23-8. PubMed ID: 21489839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.